Table 3.
Mean ± std. dev. RMS errors (%MVC), three limb-absent subjects.
| Condition | DoF(s) | ||
|---|---|---|---|
|
| |||
| 1-DoF Models (2 electrodes) | Ext-Flx | Rad-Uln | Pro-Sup |
| Assessed on 1-DoF trials | 13.7 ± 1.2 | 17.1 ± 4.1 | 13.8 ± 2.1 |
| 2-DoF Models (4 electrodes) | Ext-Flx & Rad-Uln | Ext-Flx & Pro-Sup | Rad-Uln & Pro-Sup |
|
| |||
| Assessed on 1-DoF trials: | |||
| Train with 1-DoF trials | 11.9 ± 1.3 | 14.0 ± 2.7 | 12.5 ± 2.5 |
| Train with 2- DoF trials | 38.4 ± 7.2 | 35.9 ± 18.6 | 19.5 ± 3.4 |
| Train with 1-, 2- DoF trials | 12.3 ± 1.4 | 13.9 ± 2.4 | 11.9 ± 2.1 |
|
| |||
| Assessed on 2-DoF trials: | |||
| Train with 1-DoF trials | 20.2 ± 2.5 | 21.0 ± 5.4 | 17.9 ± 3.9 |
| Train with 2-DoF trials | 24.2 ± 2.2 | 20.0 ± 3.2 | 16.6 ± 1.8 |
| Train with 1-, 2-DoF trials | 16.3 ± 1.0 | 16.7 ± 2.8 | 15.8 ± 0.4 |